Out of a target of 1,250, a total of 551 health workers administered Covaxin on 16 and 18 January, shows data. While 314 got the shot Saturday, the number fell to 237 Monday.
Several factors, including limited stocks and a global urgency to vaccinate the vulnerable, will mean it will be a while before one can buy the shot at a store.
Both Bharat Biotech and SII released factsheets indicating which categories of people should be exempted from the list of beneficiaries. See the full list here.
Without a data system, India is bound to land in a situation where minimal to nil insights are gained from possibly the largest vaccination drive in the world.
Covaxin will be sent to 7 countries, including Mongolia and Oman, while Covishield will be sent to Bhutan & Afghanistan, among others, to help ‘meet immediate requirements’.
One AIIMS health worker reported to be a severe AEFI case. He was hospitalised after receiving a Covaxin shot. However, Union ministry maintained there was no hospitalisation case.
Doctors in Assam, Maharashtra, Haryana say there’s no reason to not take Covaxin. But some AIIMS doctors in Delhi say they want to wait for the safety and efficacy data.
Confronting only secular insurgents in Pakistan, while overlooking jihadist groups operating from Iran, will do little to change the broader strategic equilibrium. History underlines this point.
A public meeting, where the women voiced their protest, took place this month in Delhi, grounded on the findings of an AIDWA survey, covering 9,000 women borrowers.
Joint Doctrine for Special Forces Operations, released Wednesday, also outlines plans for the future expansion of AFSOD and the creation of Joint Service Training Institutes.
Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.
If doctors themselves are not taking Covaxin, then it sends a loud and clear message that they don’t trust the country’s regulatory authorities.
How will public then trust the government regarding these emergency approved vaccines?
We all want an indigenous vaccine to be successful, but there should be enough transparency regarding it’s data and trials. Those who are willing to take the risk can do so but it is clear they will be basically participating in a clinical trial mode.
The report says out of 1250, 551 doctors took it which is 44.08% which is very good percentage.
Also, Pfizer, Sinopharma and other drugs also having side effects and does not give 100% guarantee.
The author wants to show Covaxin in negative way. I dont understand his intention.
If doctors themselves are not taking Covaxin, then it sends a loud and clear message that they don’t trust the country’s regulatory authorities.
How will public then trust the government regarding these emergency approved vaccines?
We all want an indigenous vaccine to be successful, but there should be enough transparency regarding it’s data and trials. Those who are willing to take the risk can do so but it is clear they will be basically participating in a clinical trial mode.